CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- 8-K Event Executive or director change
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Planned sale Director sold 22,000 shares at an average $9.51 ($209,181)
- 144 Insider Sale of Securities
- 8-K Event Other events
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 4 Planned sale Director sold 42,377 shares at an average $9.75 ($413,366)
- 4 Planned sale SVP, Chief Accounting Officer sold 1,430 shares at $9.53 ($13,632)
- 4 Planned sale EVP & Chief Financial Officer sold 1,634 shares at $9.53 ($15,576)
- 4 Planned sale EVP and Chief Medical Officer sold 3,505 shares at an average $9.69 ($33,955)
- 4 Planned sale EVP, General Counsel, Corp Sec sold 16,817 shares at an average $9.77 ($164,247)
- 4 Planned sale Chief Executive Officer sold 14,762 shares at $9.53 ($140,720)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale SVP, Chief Accounting Officer sold 1,829 shares at $7.45 ($13,631)
- 4 Planned sale EVP & Chief Financial Officer sold 2,089 shares at $7.45 ($15,569)
- 4 Planned sale EVP and Chief Medical Officer sold 2,089 shares at $7.45 ($15,569)
- 4 Planned sale EVP, General Counsel, Corp Sec sold 4,445 shares at $7.45 ($33,128)
Page 4 of 41 · 804 filings